{
  "abstract": "Respiratory research in the UK is underfunded, undervalued and suboptimally coordinated. With poor lung health costing the economy ∼£190 billion per year 1 and someone in the UK dying of a respiratory condition every 5 min,2 the economic and public health impact of respiratory conditions can and should no longer be ignored. Despite best efforts as a research community to deliver much needed advancements in the understanding and treatment of respiratory conditions, progress is hindered by inadequate funding. Respiratory research receives just 2.5% of public funding,3 a figure clearly disproportionate to the burden of disease as lung conditions are the UK’s third leading cause of death and will affect 12 million people during their lifetime.2 This discrepancy is striking when compared with the proportions of public funding allocated to other leading causes of death and harm, such as cancer (16.8%) and mental health (6.1%).3",
  "authors": [
    {
      "affiliations": [
        "Research and Innovation, Asthma + Lung UK, London, UK"
      ],
      "name": "Ellen J Forty"
    },
    {
      "affiliations": [
        "Research and Innovation, Asthma + Lung UK, London, UK"
      ],
      "name": "Samantha M Walker"
    },
    {
      "affiliations": [
        "National Heart and Lung Institute, Imperial College, London, UK"
      ],
      "name": "Eric W F W Alton"
    },
    {
      "affiliations": [
        "Queens Medical Centre, Nottingham, UK"
      ],
      "name": "Ian P Hall"
    }
  ],
  "title": "Lung Research Grand Challenges: transforming respiratory research",
  "uid": "004f3860-cb85-58dd-b70b-9f53b318f274"
}